A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease Devyani Chowdhury, MD, Kaie.

Slides:

Advertisements

Similar presentations

The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications Jih-Shiuan Wang, MD, Dominique.

Advertisements

Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

Surgery for congenital diseases of the aorta

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

The surgical and interventional hybrid era: Experiences from China

The days of future past Neel K. Ranganath, MD, Aubrey C. Galloway, MD

Building a bioartificial heart: A 3-song saga

Thoracoscopic management of postoperative esophageal leak

Risk factors for early hospital readmission after cardiac operations

Murray H. Kwon, MD The Journal of Thoracic and Cardiovascular Surgery

N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery Rowan Walsh, MD, Clark Boyer,

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

The incidence of vasoplegia in adult patients with right-sided congenital heart defects undergoing cardiac surgery and the correlation with serum vasopressin.

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

Application of a neuroscience research model to study neuroprotection in children with congenital heart disease Nobuyuki Ishibashi, MD, Richard A. Jonas,

Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery Vincent Chan, MD, MPH, Thierry.

How should we treat air leaks?

Go on-pump or off-pump in diabetic patients?

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

Transaortic endarterectomy of renal visceral artery lesions in association with infrarenal aortic surgery Robert A. Mason, MD, George B. Newton, MD,

The lord of the rings Antonio Miceli, MD, PhD

The unintended consequences in clinical research

Franco Stella, MD, PhD, Francesco Petrella, MD

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Support Your Specialty

It's not “just a shunt” but sometimes it should be…

Bartley P. Griffith, MD, FACS, FRCS

A first start for lung transplantation?

Confusion still exists regarding postoperative delirium and its etiology after esophagectomy Robert B. Cameron, MD The Journal of Thoracic and Cardiovascular.

Stephen R. Broderick, MD, MPHS

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Impact of high thoracic epidural anesthesia on incidence of perioperative atrial fibrillation in off-pump coronary bypass grafting: A prospective randomized.

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Marc Licker, MD, John Diaper, RA

Cardiac surgery with deep hypothermic circulatory arrest produces less systemic inflammatory response than low-flow cardiopulmonary bypass in newborns

Mitral homografts for total tricuspid valve replacement: Comparison of two techniques Ulrik Hvass, MD, Frank Baron, MD, Dominique Fourchy, MD, Yves Pansard,

Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes Sitaram M. Emani, MD The Journal of Thoracic.

O. S. Breathnach, MDa, D. J. Kwiatkowski, MD, PhDb, D. M

Functional tricuspid pathology: To treat or not to treat

Changes in S100β protein levels in cerebrospinal fluid after thoracoabdominal aortic operations Takashi Kunihara, MD, PhD, Norihiko Shiiya, MD, PhD,

Is single-dose prophylactic gentamicin associated with acute kidney injury in patients undergoing cardiac surgery? A matched-pair analysis Dorthe Viemose.

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tai Ji: The law of inflammatory response

The future of cardiac surgery training: A survival guide

Apparently, size matters…in congenital heart disease and brain injury

Hope should not spring eternal

The continuing challenge of congenital heart disease in China

Commentary: All aboard the transcatheter express—Road map for surgeons to develop expertise in catheter-based treatment of structural heart disease Grayson.

Building a clinical program in a single institution

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

“The more things change…”: The challenges ahead

Commentary: Judgment day: Should you add atrial fibrillation ablation?

Toward a more rational approach in treating type B aortic dissection

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

Preoperative PFTs: The answer is blowing in the wind

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

How do we follow up our patients

Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions Alan B. Lumsden, MD, Eugene R. Heyman, PhD Journal.

Deciding how much to pay for effective care

Presentation transcript:

A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease Devyani Chowdhury, MD, Kaie Ojamaa, PhD, Vincent A. Parnell, MD, Claire McMahon, MD, Cristina P. Sison, PhD, Irwin Klein, MD The Journal of Thoracic and Cardiovascular Surgery Volume 122, Issue 5, Pages 1023-1025 (November 2001) DOI: 10.1067/mtc.2001.116192 Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

Fig. 1 Preoperative and postoperative serum total T3 levels in pediatric patients undergoing operations for congenital heart disease. Mean ± SE serum total T3 concentrations in all study patients who were randomized to the T3-treated (n = 14) or the untreated (n = 14) groups or were not eligible for randomization (nonrandomized group, n = 47) are shown. Preoperative serum samples were drawn in the operating room after induction of anesthesia. Postoperative serum samples were drawn immediately after the operation. Day 0 of randomization into the study represents serum total T3 values obtained 24 to 48 hours after the operation. To convert values for T3 to nanomoles per liter, multiply by 0.015. All data points between postoperative day 1 and 5 are significantly different among the 3 groups (P ||.05). The Journal of Thoracic and Cardiovascular Surgery 2001 122, 1023-1025DOI: (10.1067/mtc.2001.116192) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions